Diplomat Pharmacy (NYSE: DPLO) announced that it will offer IRESSA (gefitinib), recently approved by the U.S. Food and Drug Administration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE